NUR 600 Advanced Clinical Pharmacology Exam
QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest
Guidelines | Graded A+
SECTION 1: CORE PRINCIPLES - PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A patient with hepatic cirrhosis is prescribed a drug with a high first-pass
metabolism. Which pharmacokinetic change is most likely to occur?
A. Decreased oral bioavailability
B. Increased oral bioavailability
C. Decreased volume of distribution
D. Increased renal clearance
Answer: B
Rationale: In hepatic cirrhosis, liver function is impaired, reducing first-pass
metabolism. Drugs that normally undergo extensive hepatic metabolism will have
less degradation during their first pass through the liver, resulting in increased
systemic availability when taken orally .
Question 2
A drug that is highly protein-bound is administered to a patient with severe
hypoalbuminemia. What is the most likely pharmacokinetic consequence?
A. Decreased free drug concentration
B. Increased free drug concentration
C. Decreased elimination half-life
D. Reduced drug efficacy
,Answer: B
Rationale: Low albumin levels reduce available binding sites for drugs. This
increases the fraction of unbound (active) drug in plasma, which can enhance
pharmacologic effects and increase the risk of toxicity .
Question 3
A medication follows zero-order kinetics. Which statement best describes its
elimination?
A. A constant percentage of the drug is eliminated per unit time
B. Elimination depends on renal perfusion
C. A constant amount of the drug is eliminated per unit time
D. Elimination rate decreases as concentration increases
Answer: C
Rationale: Zero-order elimination (e.g., phenytoin, high-dose aspirin) saturates
enzymes, eliminating a fixed amount per hour, leading to variable half-life .
Question 4
A drug has a half-life of 8 hours. Approximately how many hours until steady state
is reached?
A. 8 hours
B. 16 hours
C. 24 hours
D. 40 hours
Answer: D
Rationale: Steady state is typically reached after about 4–5 half-lives. For a drug
with an 8-hour half-life, this equates to approximately 32–40 hours, making 40
hours the best answer .
, Question 5
A patient is given a drug that acts as a partial agonist at a receptor. Which
outcome is most likely when this drug is administered alongside a full agonist?
A. It produces a greater maximal response than the full agonist
B. It reduces the effect of the full agonist
C. It has no effect on the full agonist's activity
D. It irreversibly binds to the receptor
Answer: B
Rationale: Partial agonists have lower intrinsic activity compared to full agonists.
When both compete for the same receptor, the partial agonist occupies receptors
but produces a weaker response, thereby diminishing the overall effect of the full
agonist .
Question 6
A patient's nutritional intake and lab work reflect hypoalbuminemia. This is critical
to prescribing because:
A. Distribution of drugs to target tissue may be affected
B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney
Answer: A
Rationale: Albumin is a major binding protein for many drugs. Hypoalbuminemia
leads to a higher proportion of free (unbound) drug, which can increase drug
effects and toxicity, and alter distribution to target tissues .
Question 7
Drugs that have a significant first-pass effect:
A. Must be given by the enteral (oral) route only
B. Bypass the hepatic circulation
QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest
Guidelines | Graded A+
SECTION 1: CORE PRINCIPLES - PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A patient with hepatic cirrhosis is prescribed a drug with a high first-pass
metabolism. Which pharmacokinetic change is most likely to occur?
A. Decreased oral bioavailability
B. Increased oral bioavailability
C. Decreased volume of distribution
D. Increased renal clearance
Answer: B
Rationale: In hepatic cirrhosis, liver function is impaired, reducing first-pass
metabolism. Drugs that normally undergo extensive hepatic metabolism will have
less degradation during their first pass through the liver, resulting in increased
systemic availability when taken orally .
Question 2
A drug that is highly protein-bound is administered to a patient with severe
hypoalbuminemia. What is the most likely pharmacokinetic consequence?
A. Decreased free drug concentration
B. Increased free drug concentration
C. Decreased elimination half-life
D. Reduced drug efficacy
,Answer: B
Rationale: Low albumin levels reduce available binding sites for drugs. This
increases the fraction of unbound (active) drug in plasma, which can enhance
pharmacologic effects and increase the risk of toxicity .
Question 3
A medication follows zero-order kinetics. Which statement best describes its
elimination?
A. A constant percentage of the drug is eliminated per unit time
B. Elimination depends on renal perfusion
C. A constant amount of the drug is eliminated per unit time
D. Elimination rate decreases as concentration increases
Answer: C
Rationale: Zero-order elimination (e.g., phenytoin, high-dose aspirin) saturates
enzymes, eliminating a fixed amount per hour, leading to variable half-life .
Question 4
A drug has a half-life of 8 hours. Approximately how many hours until steady state
is reached?
A. 8 hours
B. 16 hours
C. 24 hours
D. 40 hours
Answer: D
Rationale: Steady state is typically reached after about 4–5 half-lives. For a drug
with an 8-hour half-life, this equates to approximately 32–40 hours, making 40
hours the best answer .
, Question 5
A patient is given a drug that acts as a partial agonist at a receptor. Which
outcome is most likely when this drug is administered alongside a full agonist?
A. It produces a greater maximal response than the full agonist
B. It reduces the effect of the full agonist
C. It has no effect on the full agonist's activity
D. It irreversibly binds to the receptor
Answer: B
Rationale: Partial agonists have lower intrinsic activity compared to full agonists.
When both compete for the same receptor, the partial agonist occupies receptors
but produces a weaker response, thereby diminishing the overall effect of the full
agonist .
Question 6
A patient's nutritional intake and lab work reflect hypoalbuminemia. This is critical
to prescribing because:
A. Distribution of drugs to target tissue may be affected
B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney
Answer: A
Rationale: Albumin is a major binding protein for many drugs. Hypoalbuminemia
leads to a higher proportion of free (unbound) drug, which can increase drug
effects and toxicity, and alter distribution to target tissues .
Question 7
Drugs that have a significant first-pass effect:
A. Must be given by the enteral (oral) route only
B. Bypass the hepatic circulation
